Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

All you need to know about vaccines and infectious diseases in one handy app!

The Vaccine Knowledge App is based on the information on the Vaccine Knowledge website developed by the Oxford Vaccine Group in our Department. It contains ‘bite-sized’ sections on every aspect of vaccines and infectious diseases in the UK. It provides clear, relevant and unbiased information in a user-friendly format which can be accessed ‘on the go’. You can also access all our short films, and there is a personalised section where you can enter your child’s date of birth to find out which vaccines they are due. To our knowledge, this is the only app of its type so far developed for a UK audience.

 

 

Similar stories

New clinical trials begin in Burkina Faso

Vaccinations have started at the Institut de Recherche en Sciences de la Santé – Clinical Research Unit of Nanoro (IRSS-URCN), Burkina Faso for two clinical trials to assess the blood-stage malaria vaccine candidates R78C and RH5.1 with Matrix-M (developed by the Draper Lab in the Department of Paediatrics), in combination with the R21/​Matrix-M vaccine, which targets the earlier liver-stage. The trials are sponsored by the University of Oxford (UOXF), UK, with the European Vaccine Initiative (EVI) acting as both a co-funder and collaborator. These exciting studies are expected to provide proof-of-concept for the use of a multi-stage vaccine to extend the protection against malaria and help lead to future efforts to eliminate it by targeting two stages of the parasite’s life-cycle.